SL
BIO icon

Savior LLC’s Bio-Rad Laboratories Class A BIO Stock Holding History

Savior LLC’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-8
Closed -$5K – 247
2021
Q2 		$5K Sell
8
-17
-68% -$10.3K ﹤0.01% 554
2021
Q1 		$14K Hold
25
– – 0.01% 345
2020
Q4 		$15K Hold
25
– – 0.01% 328
2020
Q3 		$13K Hold
25
– – 0.02% 322
2020
Q2 		$11K Hold
25
– – 0.01% 319
2020
Q1 		$9K Hold
25
– – 0.01% 331
2019
Q4 		$9K Buy
+25
New +$8.81K 0.01% 441

Other funds holding BIO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Savior LLC's BIO Position: Q3 2021 in Review

Savior LLC sold out of Bio-Rad Laboratories Class A (BIO) in Q3 2021, closing a stake of 8 shares — an estimated $5K sold.

Savior LLC first reported a position in BIO in Q4 2019 and held it in 7 quarters. The position peaked at $15K in Q4 2020. 508 funds tracked by Wall St. Rank hold BIO as of Q3 2021.

  • Savior LLC reported no remaining Bio-Rad Laboratories Class A position as of Q3 2021 after selling out during the quarter.
  • Savior LLC sold 8 Bio-Rad Laboratories Class A shares in Q3 2021, an estimated $5K.
  • Savior LLC first reported a position in Bio-Rad Laboratories Class A in Q4 2019 and held it in 7 quarters.
  • Savior LLC's Bio-Rad Laboratories Class A position peaked at $15K in Q4 2020.
  • 508 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q3 2021.

Based on Savior LLC's 13F filing for Q3 2021, filed 5 Oct 2021.